Growth ForecastsManagement raised its FY24 currency-neutral growth forecasts across key metrics, highlighting confidence and visibility.
Market OpportunityThe U.S. is identified as the world’s most profitable nicotine market and a significant opportunity for PM, with iQOS in the US estimated to be 3-4x more profitable at scale than its international cigarette business.
Strategic MovesPM announced the sale of its subsidiary Vectura Group to Molex Asia Holdings and the establishment of master service agreement to develop Vectura Fertin Pharma’s inhaled therapeutics pipeline.